Established in the year 1995, Syncom Formulations is a global pharmaceutical company that manufactures and markets a broad range of healthcare products. The company is a generic pharmaceutical player operating in more than 15 countries worldwide having more than 400 products registered.
Financial Results:
Syncom Formulations (India) Ltd reported Revenues for Q1FY24 of ₹59.36 Crores up from ₹51.40 Crore year on year, a rise of 15.49%.
Total Expenses for Q1FY24 of ₹55.43 Crores up from ₹49.42 Crores year on year, a rise of 12.16%.
Consolidated Net Profit of ₹4.25 Crores up 9.82% from ₹3.87 Crores in the same quarter of the previous year.
The Earnings per Share is ₹0.05, up 25.00% from ₹0.04 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.